Brief: Chemometec H1 EBITDA DKK 135.2 Million
05/02/2025 17:55
Feb 05 (Reuters) - Chemometec H1 EBITDA margin 54%. * H1 revenue DKK 251.5 million * outlook FY EBITDA DKK 250-260 million
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation